BioNTech SE (XBUL:22UA)
лв 110 0 (0%) Market Cap: 26.37 Bil Enterprise Value: -7.22 Bil PE Ratio: 0 PB Ratio: 1.23 GF Score: 50/100

Q1 2023 BioNTech SE Earnings Call Transcript

May 08, 2023 / 12:00PM GMT
Operator

Welcome to the BioNTech First Quarter 2023 Update Call.

I would like to hand the call over to Dr. Victoria Meissner, Vice President of Strategy and Investor Relations. Please go ahead.

Victoria Meissner

Good morning and afternoon. My name is Victoria Meissner, and I'm the new Head of Investor Relations at BioNTech. I'm a medical doctor by training and have recently joined BioNTech from Healthcare Investment Banking at Jefferies. I look forward to working with you on the corporate side.

Thank you for joining us today for BioNTech's First Quarter 2023 Earnings Call. As a brief reminder, the slides that accompany this call and the first quarter 2023 press release that was issued this morning can be found in the Investors section of our website.

As outlined on Slide 2, you can see our forward-looking statements disclaimer. Additional information about these statements and other risks are described in our filings made with the U.S. Securities and Exchange Commission. Forward-looking statements on the call are subject to substantial risks and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot